Miocamycin
Miocamycin (Midecamycin acetate) is a derivative of midecamycin (HY-B1908), a macrolide antibiotic that can be isolated from a culture broth of Streptomyces mycarofaciens. Miocamycin has antibacterial properties[1].
Product Specifications
CAS Number
[55881-07-7]
Product Name Alternative
Midecamycin acetate; Ponsinomycin
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/miocamycin.html
Solubility
10 mM in DMSO
Smiles
CO[C@@H]([C@@H](CC(O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]1CC=O)C)OC(C)=O)C)=O)OC(CC)=O)[C@H]1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@](C)([C@H]([C@@H](O3)C)OC(CC)=O)OC(C)=O)N(C)C)O
Molecular Formula
C45H71NO17
Molecular Weight
898.04
References & Citations
[1]TOXICOLOGICAL STUDIES ON A NEW MACROLIDE ANTIBIOTIC, MIDECAMYCIN ACETATE (MIOCAMYCIN) . July 1984. Volume 37 Issue 7 Pages 1355-1375.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
53573151 3x 1.0 µg DNA
C11orf66 CRISPR All-in-one AAV vector set (with saCas9)(Human)
Ask
View Details 